To deal with relapsed or refractory mantle mobile lymphoma in Grown ups which have experienced at the very least two lines of systemic therapy, which includes a BTK inhibitor Substances for which a petition has been filed but denied as a consequence of not enough proof of basic safety. https://proleviate.com/